<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:55:59Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7367615" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7367615</identifier>
        <datestamp>2020-07-20</datestamp>
        <setSpec>canmed</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Cancer Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Cancer Med</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2045-7634</journal-id>
              <journal-id journal-id-type="publisher-id">CAM4</journal-id>
              <journal-title-group>
                <journal-title>Cancer Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2045-7634</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7367615</article-id>
              <article-id pub-id-type="pmcid">PMC7367615</article-id>
              <article-id pub-id-type="pmc-uid">7367615</article-id>
              <article-id pub-id-type="pmid">32483861</article-id>
              <article-id pub-id-type="doi">10.1002/cam4.3188</article-id>
              <article-id pub-id-type="publisher-id">CAM43188</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Clinical Cancer Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Original Research</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>L‚ÄêDex, arm volume, and symptom trajectories 24 months after breast cancer surgery</article-title>
                <alt-title alt-title-type="left-running-head">RIDNER et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="cam43188-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Ridner</surname>
                    <given-names>Sheila H.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3847-7405</contrib-id>
                  <xref ref-type="aff" rid="cam43188-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>sheila.ridner@vanderbilt.edu</email>
                  </address>
                </contrib>
                <contrib id="cam43188-cr-0002" contrib-type="author">
                  <name>
                    <surname>Shah</surname>
                    <given-names>Chirag</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0003" contrib-type="author">
                  <name>
                    <surname>Boyages</surname>
                    <given-names>John</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0004" contrib-type="author">
                  <name>
                    <surname>Koelmeyer</surname>
                    <given-names>Louise</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2736-2330</contrib-id>
                  <xref ref-type="aff" rid="cam43188-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0005" contrib-type="author">
                  <name>
                    <surname>Ajkay</surname>
                    <given-names>Nicolas</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0006" contrib-type="author">
                  <name>
                    <surname>DeSnyder</surname>
                    <given-names>Sarah M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0007" contrib-type="author">
                  <name>
                    <surname>McLaughlin</surname>
                    <given-names>Sarah A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="cam43188-cr-0008" contrib-type="author">
                  <name>
                    <surname>Dietrich</surname>
                    <given-names>Mary S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cam43188-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="cam43188-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <institution>Vanderbilt University School of Nursing</institution>
                <city>Nashville</city>
                <named-content content-type="country-part">TN</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam43188-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Radiation Oncology</named-content>
                <institution>Taussig Cancer Institute</institution>
                <institution>Cleveland Clinic</institution>
                <city>Cleveland</city>
                <named-content content-type="country-part">OH</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam43188-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Australian Lymphoedema Education, Research, and Treatment (ALERT) Program</named-content>
                <named-content content-type="organisation-division">Faculty of Medicine &amp; Health Sciences</named-content>
                <institution>Macquarie University</institution>
                <city>Sydney</city>
                <named-content content-type="country-part">NSW</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cam43188-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">ALERT Program</named-content>
                <named-content content-type="organisation-division">Faculty of Medicine &amp; Health Sciences</named-content>
                <institution>Macquarie University</institution>
                <city>Sydney</city>
                <named-content content-type="country-part">NSW</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cam43188-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Breast Surgical Oncology</named-content>
                <institution>University of Louisville</institution>
                <city>Louisville</city>
                <named-content content-type="country-part">KY</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam43188-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Department of Breast Surgical Oncology</named-content>
                <institution>The University of Texas MD Anderson Cancer Center</institution>
                <city>Houston</city>
                <named-content content-type="country-part">TX</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam43188-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Surgery</named-content>
                <institution>Mayo Clinic</institution>
                <city>Jacksonville</city>
                <named-content content-type="country-part">FL</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam43188-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <institution>Vanderbilt University School of Nursing and Vanderbilt University School of Medicine</institution>
                <city>Nashville</city>
                <named-content content-type="country-part">TN</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Correspondence<break/>
Sheila H. Ridner, 524 Godchaux Hall, 416 21st Avenue, South Nashville, TN 37240, USA.<break/>
Email: <email>sheila.ridner@vanderbilt.edu</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>01</day>
                <month>6</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2020</year>
              </pub-date>
              <volume>9</volume>
              <issue>14</issue>
              <issue-id pub-id-type="doi">10.1002/cam4.v9.14</issue-id>
              <fpage>5164</fpage>
              <lpage>5173</lpage>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>1</month>
                  <year>2020</year>
                </date>
                <date date-type="rev-recd">
                  <day>14</day>
                  <month>4</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>02</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Published by John Wiley & Sons Ltd. <copyright-statement>-->
                <copyright-statement content-type="article-copyright">¬© 2020 The Authors. <italic>Cancer Medicine</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:CAM4-9-5164.pdf"/>
              <abstract id="cam43188-abs-0001">
                <title>Abstract</title>
                <sec id="cam43188-sec-0001">
                  <title>Purpose</title>
                  <p>Study objectives were to examine: (a) biomarker trajectories (change from presurgical baseline values of Lymphedema index (L‚ÄêDex) units and arm volume difference) and symptom cluster scores 24¬†months after breast cancer surgery and (b) associations of these objective biomarkers and symptom cluster scores. Patient/treatment characteristics influencing trajectories were also evaluated.</p>
                </sec>
                <sec id="cam43188-sec-0002">
                  <title>Methods</title>
                  <p>A secondary analysis of data from the published interim analysis of a randomized parent study was undertaken using trajectory analysis. Five hundred and eight participants included in the prior analysis with 24¬†months of postsurgical follow‚Äêup were initially measured with bioelectric impedance spectroscopy (BIS) and tape measure (TM) and completed self‚Äêreport measures. Patients were reassessed postsurgery for continuing eligibility and then randomized to either BIS or TM groups and measured along with self‚Äêreport data at regular and optional* visits 3, 6,12,15*,18, 21*, and 24‚Äêmonths.</p>
                </sec>
                <sec id="cam43188-sec-0003">
                  <title>Results</title>
                  <p>Three subclinical trajectories were identified for each biomarker (decreasing, stable, increasing) and symptom cluster scores (stable, slight increase/decrease, increasing). Subclinical lymphedema was identified throughout the 24‚Äêmonth period by each biomarker. An L‚ÄêDex increase at 15¬†months in the BIS group was noted. The self‚Äêreport sets demonstrated contingency coefficients of 0.20 (LSIDS‚ÄêA soft tissue, <italic>P</italic>¬†=¬†.031) and 0.19 (FACTB+4, <italic>P</italic>¬†=¬†.044) with the L‚ÄêDex unit change trajectories.</p>
                </sec>
                <sec id="cam43188-sec-0004">
                  <title>Conclusions</title>
                  <p>These data support the need for long‚Äêterm (24¬†months) prospective surveillance with frequent assessments (every 3¬†months) at least 15¬†months after surgery. Statistically significant convergence of symptom cluster scores with L‚ÄêDex unit change supports BIS as beneficial in the early identification of subclinical lymphedema.</p>
                </sec>
              </abstract>
              <abstract abstract-type="graphical" id="cam43188-abs-0002">
                <p>Long‚Äêterm (24¬†months) lymphedema prospective surveillance with frequent assessments (every 3¬†months) at least through 15‚Äêmonths post‚Äêsurgery is indicated. Convergence of symptom cluster scores with L‚ÄêDex unit change supports Bioelectric Impedance Spectroscopy as beneficial in the early identification of sub‚Äêclinical lymphedema.<boxed-text position="anchor" content-type="graphic" id="cam43188-blkfxd-0001" orientation="portrait"><graphic xlink:href="CAM4-9-5164-g005.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
</p>
              </abstract>
              <kwd-group>
                <kwd id="cam43188-kwd-0001">biomarkers</kwd>
                <kwd id="cam43188-kwd-0002">breast cancer</kwd>
                <kwd id="cam43188-kwd-0003">quality of life</kwd>
                <kwd id="cam43188-kwd-0004">survival</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>Center for Scientific Review </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100005440</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NIH/NCATS UL1 TR000445</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>ImpediMed</funding-source>
                  <award-id>N/A</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>medi</funding-source>
                  <award-id>N/A</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="2"/>
                <page-count count="10"/>
                <word-count count="5513"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>July 2020</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.5 mode:remove_FC converted:17.07.2020</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="cam43188-cit-1001"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Shah</surname><given-names>C</given-names></string-name>, <string-name><surname>Boyages</surname><given-names>J</given-names></string-name>, et al. <article-title>L‚ÄêDex, arm volume, and symptom trajectories 24 months after breast cancer surgery</article-title>. <source xml:lang="en">Cancer Med</source>. <year>2020</year>;<volume>9</volume>:<fpage>5164</fpage>‚Äì<lpage>5173</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.3188</pub-id>
</mixed-citation>
              </p>
              <fn-group id="cam43188-ntgp-0001">
                <fn fn-type="funding" id="cam43188-note-0001">
                  <p>
                    <bold>FUNDING</bold>
                  </p>
                  <p>This study was funded by ImpediMed, medi, and by the National Institutes of Health (NIH/NCATS UL1 TR000445).</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="cam43188-body-0001">
            <sec id="cam43188-sec-0005">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Breast cancer‚Äêrelated lymphedema (BCRL) results in quality‚Äêof‚Äêlife altering treatment sequelae for approximately 20%‚Äê30% of breast cancer survivors (BCS).<xref rid="cam43188-bib-0001" ref-type="ref"><sup>1</sup></xref> The identification of initial increases in lymphatic fluid (subclinical lymphedema) after cancer treatment, when coupled with an early short‚Äêterm compression intervention, is thought to reduce rates of progression to clinical lymphedema.<xref rid="cam43188-bib-0002" ref-type="ref"><sup>2</sup></xref>, <xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> Thus, since the publication of the Stout et al study in 2008, consensus has grown that prospective surveillance after breast cancer treatment is needed to promote early identification of subclinical lymphedema to facilitate noninvasive interventions that reduce burden and cost of clinical lymphedema.<xref rid="cam43188-bib-0004" ref-type="ref"><sup>4</sup></xref>, <xref rid="cam43188-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="cam43188-bib-0006" ref-type="ref"><sup>6</sup></xref> Prospective surveillance requires longitudinal assessments of patients‚Äô arm status, preferably with baseline measurements before treatment commences and serially thereafter.</p>
              <p>Biomarkers are increasingly being studied in oncology and serve as objective indicators,<xref rid="cam43188-bib-0007" ref-type="ref"><sup>7</sup></xref> ‚Äú‚Ä¶reflecting an interaction between a biological system and an environmental agent, which may be chemical, physical or biological.‚Äù<xref rid="cam43188-bib-0008" ref-type="ref"><sup>8</sup></xref> In the case of lymphedema, Lymphedema index (L‚ÄêDex) units<sup>¬Æ</sup> and arm volume function as biomarkers. An L‚ÄêDex unit change of ‚â•6.5 from presurgical baseline and a tape measure (TM) volume difference change of ‚â•5% but &lt;10% are considered subclinical BCRL and values exceeding these thresholds for each measure represent clinical lymphedema.<xref rid="cam43188-bib-0009" ref-type="ref"><sup>9</sup></xref>
</p>
              <p>Little is known about the longitudinal patterns of change in L‚ÄêDex units and arm volume difference in relation to subclinical BCRL.<xref rid="cam43188-bib-0001" ref-type="ref"><sup>1</sup></xref>, <xref rid="cam43188-bib-0010" ref-type="ref"><sup>10</sup></xref> This contributes to the absence of both standardized monitoring intervals and monitoring duration for BCRL prospective surveillance.<xref rid="cam43188-bib-0011" ref-type="ref"><sup>11</sup></xref> In the case of lymphedema biomarkers, trajectory analysis of change in L‚ÄêDex units and arm volume percent difference from baseline, combined with symptoms, could provide information to fill this gap.<xref rid="cam43188-bib-0012" ref-type="ref"><sup>12</sup></xref>, <xref rid="cam43188-bib-0013" ref-type="ref"><sup>13</sup></xref> The objectives of this secondary study were to examine: (a) the trajectories of objective biomarkers (change from presurgical baseline values of L‚ÄêDex units and in percentage arm volume difference) and subjective symptom clusters over 24¬†months after surgery; and (b) associations of objective biomarkers and subjective symptom clusters. Secondarily, patient/treatment characteristics influencing the trajectories of interest were explored. It was hypothesized that longitudinal patterns in biomarkers and symptom clusters would be identified.</p>
            </sec>
            <sec id="cam43188-sec-0006">
              <label>2</label>
              <title>PATIENTS AND METHODS</title>
              <sec id="cam43188-sec-0007">
                <label>2.1</label>
                <title>Study setting and design</title>
                <p>This study is comprised of data from an ongoing multi‚Äêsite, international randomized controlled trial and was conducted in accordance with the Declaration of Helsinki. Institutional Review Board approval was gained from all sites. Scientific Review Committee approval was acquired when applicable. All sites obtained informed consent prior to study enrollment.</p>
              </sec>
              <sec id="cam43188-sec-0008">
                <label>2.2</label>
                <title>Patients</title>
                <p>Newly diagnosed patients with breast cancer (N¬†=¬†1201) who met previously described inclusion criteria were enrolled in the parent study and randomized postsurgery to prospective surveillance via Bioimpedance spectroscopy (BIS) or TM.<xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> Patients underwent a lymphedema prevention intervention with a compression sleeve and gauntlet when subclinical lymphedema was identified.<xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> An interim analysis from the parent study included data from 508 participants with 12¬†months of postsurgical follow‚Äêup and addressed progression to complex decongestive physiotherapy.<xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> This study includes participants from the interim analysis who have completed at least 24¬†months of follow‚Äêup after date of first surgery and addresses subclinical BCRL.</p>
              </sec>
              <sec id="cam43188-sec-0009">
                <label>2.3</label>
                <title>Procedures</title>
                <sec id="cam43188-sec-0010">
                  <label>2.3.1</label>
                  <title>Measures</title>
                  <sec id="cam43188-sec-0011">
                    <title>Sociodemographic and medical characteristics</title>
                    <p>A self‚Äêreport questionnaire captured these variables for the sample that have been previously reported.<xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> Comorbidity and medication histories were obtained via self‚Äêreport and medical records.</p>
                  </sec>
                  <sec id="cam43188-sec-0012">
                    <title>Biomarkers</title>
                    <p>The ImpediMed L‚ÄêDex<sup>¬Æ</sup> U400<xref rid="cam43188-bib-0014" ref-type="ref"><sup>14</sup></xref> was used to evaluate extracellular fluid following manufacturer‚Äôs procedures. Limb volume change was assessed using a nonflexible Gulick II<xref rid="cam43188-bib-0015" ref-type="ref"><sup>15</sup></xref> tape according to study protocol.</p>
                  </sec>
                  <sec id="cam43188-sec-0013">
                    <title>Symptoms</title>
                    <p>The Lymphedema Symptom Intensity and Distress Survey‚ÄêArm (LSIDS‚ÄêA) 4‚Äêitem (heavy arm, tight arm, swelling arm, hard arm) soft tissue sensation subscale<xref rid="cam43188-bib-0016" ref-type="ref"><sup>16</sup></xref> and the Functional Assessment Cancer Therapy Breast +4 (FACTB+4) 4‚Äêitem (painful movement, poor range of motion, numb, stiffness) arm subscale were used in this study.<xref rid="cam43188-bib-0017" ref-type="ref"><sup>17</sup></xref>
</p>
                  </sec>
                </sec>
              </sec>
              <sec id="cam43188-sec-0014">
                <label>2.4</label>
                <title>Data Analysis</title>
                <p>Descriptive statistics summarized baseline patient and treatment characteristics used in this study (see Tables <xref rid="cam43188-tbl-0001" ref-type="table">1</xref> and <xref rid="cam43188-tbl-0002" ref-type="table">2</xref>). Mann‚ÄêWhitney and chi‚Äêsquared tests were used to assess study group differences.</p>
                <table-wrap id="cam43188-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Patient‚Äêtreatment characteristics associations with L‚ÄêDex and tape trajectories</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Patients assessed via L‚ÄêDEX (N¬†=¬†263)</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Patients assessed via Tape (N¬†=¬†245)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Decreasing</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Stable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Increasing</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Decreasing</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Stable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Increasing</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" colspan="6" rowspan="1">Median [IQR] (N)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (y)</td>
                        <td align="left" rowspan="1" colspan="1">59<sup>a</sup> [50,68], 91</td>
                        <td align="left" rowspan="1" colspan="1">58<sup>a</sup> [49,68], 146</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>64<sup>b</sup> [56,71], 25</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">61 [49,68], 65</td>
                        <td align="left" rowspan="1" colspan="1">57 [51,65], 137</td>
                        <td align="left" rowspan="1" colspan="1">58 [50,67], 41</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                        <td align="left" rowspan="1" colspan="1">27 [23,32], 91</td>
                        <td align="left" rowspan="1" colspan="1">28 [24,33], 147</td>
                        <td align="left" rowspan="1" colspan="1">29 [24,36], 25</td>
                        <td align="left" rowspan="1" colspan="1">29 [23,33], 65</td>
                        <td align="left" rowspan="1" colspan="1">28 [24,32], 138</td>
                        <td align="left" rowspan="1" colspan="1">30 [25,35], 41</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" colspan="6" rowspan="1">N Yes (% Yes) [N responses]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Oral Steroids (N¬†=¬†7)</td>
                        <td align="left" rowspan="1" colspan="1">2 (2) [91]</td>
                        <td align="left" rowspan="1" colspan="1">4 (3) [145]</td>
                        <td align="left" rowspan="1" colspan="1">1 (4) [25]</td>
                        <td align="left" rowspan="1" colspan="1">2 (3) [65]</td>
                        <td align="left" rowspan="1" colspan="1">1 (1) [138]</td>
                        <td align="left" rowspan="1" colspan="1">2 (5) [41]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">NSAIDs</td>
                        <td align="left" rowspan="1" colspan="1">27 (30) [91]</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>29 (20)<sup>a</sup> [145]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>12 (48)<sup>b</sup> [25]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">10 (15) [66]</td>
                        <td align="left" rowspan="1" colspan="1">27 (20) [138]</td>
                        <td align="left" rowspan="1" colspan="1">11 (27) [41]</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">History</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cardiovascular</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>31 (34)<sup>b</sup> [91]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>73 (50)<sup>b</sup> [146]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">13 (52) [25]</td>
                        <td align="left" rowspan="1" colspan="1">28 (42) [66]</td>
                        <td align="left" rowspan="1" colspan="1">57 (41) [138]</td>
                        <td align="left" rowspan="1" colspan="1">21 (51) [41]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Excretory</td>
                        <td align="left" rowspan="1" colspan="1">7 (8) [91]</td>
                        <td align="left" rowspan="1" colspan="1">6 (4) [146]</td>
                        <td align="left" rowspan="1" colspan="1">3 (12) [25]</td>
                        <td align="left" rowspan="1" colspan="1">4 (6) [66]</td>
                        <td align="left" rowspan="1" colspan="1">6 (4) [138]</td>
                        <td align="left" rowspan="1" colspan="1">1 (2) [41]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">GERD</td>
                        <td align="left" rowspan="1" colspan="1">11 (69) [16]</td>
                        <td align="left" rowspan="1" colspan="1">15 (54) [28]</td>
                        <td align="left" rowspan="1" colspan="1">4 (100) [4]</td>
                        <td align="left" rowspan="1" colspan="1">12 (75) [16]</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>37 (84)<sup>a</sup> [44]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>4 (40)<sup>b</sup> [10]</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Respiratory</td>
                        <td align="left" rowspan="1" colspan="1">11 (12) [91]</td>
                        <td align="left" rowspan="1" colspan="1">21 (14) [146]</td>
                        <td align="left" rowspan="1" colspan="1">1 (4) [25]</td>
                        <td align="left" rowspan="1" colspan="1">7 (11) [66]</td>
                        <td align="left" rowspan="1" colspan="1">20 (15) [138]</td>
                        <td align="left" rowspan="1" colspan="1">8 (20) [40]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Regional node irradiation</td>
                        <td align="left" rowspan="1" colspan="1">15 (20) [75]</td>
                        <td align="left" rowspan="1" colspan="1">29 (22) [130]</td>
                        <td align="left" rowspan="1" colspan="1">6 (30) [20]</td>
                        <td align="left" rowspan="1" colspan="1">10 (19) [54]</td>
                        <td align="left" rowspan="1" colspan="1">27 (23) [117]</td>
                        <td align="left" rowspan="1" colspan="1">9 (29) [31]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">If chemo, any Taxane</td>
                        <td align="left" rowspan="1" colspan="1">32 (94) [34]</td>
                        <td align="left" rowspan="1" colspan="1">50 (85) [59]</td>
                        <td align="left" rowspan="1" colspan="1">14 (100) [14]</td>
                        <td align="left" rowspan="1" colspan="1">27 (93) [29]</td>
                        <td align="left" rowspan="1" colspan="1">48 (92) [52]</td>
                        <td align="left" rowspan="1" colspan="1">22 (88) [25]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Axillary dissection (¬±SLND)</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†87</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†139</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†24</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†63</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†133</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†36</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">ALND only</td>
                        <td align="left" rowspan="1" colspan="1">8 (9)</td>
                        <td align="left" rowspan="1" colspan="1">13 (9)</td>
                        <td align="left" rowspan="1" colspan="1">3 (13)</td>
                        <td align="left" rowspan="1" colspan="1">4 (6)</td>
                        <td align="left" rowspan="1" colspan="1">12 (9)</td>
                        <td align="left" rowspan="1" colspan="1">6 (17)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SLNB only</td>
                        <td align="left" rowspan="1" colspan="1">70 (81)</td>
                        <td align="left" rowspan="1" colspan="1">115 (83)</td>
                        <td align="left" rowspan="1" colspan="1">16 (67)</td>
                        <td align="left" rowspan="1" colspan="1">49 (78)</td>
                        <td align="left" rowspan="1" colspan="1">103 (77)</td>
                        <td align="left" rowspan="1" colspan="1">24 (67)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">ALND and SLNB</td>
                        <td align="left" rowspan="1" colspan="1">9 (10)</td>
                        <td align="left" rowspan="1" colspan="1">11 (8)</td>
                        <td align="left" rowspan="1" colspan="1">5 (21)</td>
                        <td align="left" rowspan="1" colspan="1">10 (16)</td>
                        <td align="left" rowspan="1" colspan="1">18 (14)</td>
                        <td align="left" rowspan="1" colspan="1">6 (17)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">If SLND, number ‚â•6</td>
                        <td align="left" rowspan="1" colspan="1">5 (7) [70]</td>
                        <td align="left" rowspan="1" colspan="1">1 (1) [115]</td>
                        <td align="left" rowspan="1" colspan="1">0 (0) [18]</td>
                        <td align="left" rowspan="1" colspan="1">2 (4) [49]</td>
                        <td align="left" rowspan="1" colspan="1">6 (6) [103]</td>
                        <td align="left" rowspan="1" colspan="1">1 (4) [24]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Conservative mastectomy</td>
                        <td align="left" rowspan="1" colspan="1">74 (81) [91]</td>
                        <td align="left" rowspan="1" colspan="1">121 (82) [147]</td>
                        <td align="left" rowspan="1" colspan="1">17 (68) [25]</td>
                        <td align="left" rowspan="1" colspan="1">52 (79) [66]</td>
                        <td align="left" rowspan="1" colspan="1">110 (80) [138]</td>
                        <td align="left" rowspan="1" colspan="1">27 (66) [41]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Complete treatment</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†87</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†146</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†25</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†66</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†138</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†41</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery</td>
                        <td align="left" rowspan="1" colspan="1">8 (9)</td>
                        <td align="left" rowspan="1" colspan="1">9 (6)</td>
                        <td align="left" rowspan="1" colspan="1">2 (8)</td>
                        <td align="left" rowspan="1" colspan="1">6 (9)</td>
                        <td align="left" rowspan="1" colspan="1">13 (9)</td>
                        <td align="left" rowspan="1" colspan="1">5 (12)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery + Radiotherapy</td>
                        <td align="left" rowspan="1" colspan="1">48 (55)</td>
                        <td align="left" rowspan="1" colspan="1">80 (55)</td>
                        <td align="left" rowspan="1" colspan="1">9 (36)</td>
                        <td align="left" rowspan="1" colspan="1">31 (47)</td>
                        <td align="left" rowspan="1" colspan="1">75 (54)</td>
                        <td align="left" rowspan="1" colspan="1">11 (27)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery +Chemotherapy (Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">6 (7)</td>
                        <td align="left" rowspan="1" colspan="1">6 (4)</td>
                        <td align="left" rowspan="1" colspan="1">3 (12)</td>
                        <td align="left" rowspan="1" colspan="1">8 (12)</td>
                        <td align="left" rowspan="1" colspan="1">6 (4)</td>
                        <td align="left" rowspan="1" colspan="1">5 (12)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery + Chemotherapy (Not Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery + Radiotherapy +Chemotherapy (Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">24 (28)</td>
                        <td align="left" rowspan="1" colspan="1">42 (29)</td>
                        <td align="left" rowspan="1" colspan="1">11 (44)</td>
                        <td align="left" rowspan="1" colspan="1">19 (29)</td>
                        <td align="left" rowspan="1" colspan="1">40 (29)</td>
                        <td align="left" rowspan="1" colspan="1">17 (42)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery + Radiotherapy + Chemotherapy (Not Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">8 (6)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                        <td align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td align="left" rowspan="1" colspan="1">3 (2)</td>
                        <td align="left" rowspan="1" colspan="1">3 (7)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="cam43188-ntgp-0002">
                    <fn id="cam43188-note-0002">
                      <p>Bold indicates cell with statistically significant findings (Bonferroni‚Äêcorrected <italic>P</italic>¬†&lt;¬†.05). Superscripts (<sup>a</sup>, <sup>b</sup>) indicate specifically which trajectory patterns defined the difference.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap id="cam43188-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Patient‚Äêtreatment characteristics associations with self‚Äêreported symptom trajectories</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">LSIDS‚ÄêA Soft Tissue (N¬†=¬†508)</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">FACT‚ÄêB Arm (N¬†=¬†508)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">None/Stable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Slight Increase</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Increasing</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">None/Stable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Slight Increase</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Increasing</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" colspan="6" rowspan="1">Median [IQR] (N)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (years)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>61<sup>a</sup> [52,68], 324</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">55<sup>b</sup> [48,65], 137</td>
                        <td align="left" rowspan="1" colspan="1">52<sup>b</sup> [48,59], 44</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>61<sup>a</sup> [51,68], 267</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">58 [50,66], 195</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>53<sup>b</sup> [46,60], 43</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                        <td align="left" rowspan="1" colspan="1">28 [24,32], 326</td>
                        <td align="left" rowspan="1" colspan="1">28 [24,34], 137</td>
                        <td align="left" rowspan="1" colspan="1">29 [25,33], 44</td>
                        <td align="left" rowspan="1" colspan="1">28 [25,34], 269</td>
                        <td align="left" rowspan="1" colspan="1">28 [24,32], 194</td>
                        <td align="left" rowspan="1" colspan="1">30 [25,35], 44</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" colspan="6" rowspan="1">N Yes (% Yes) [N responses]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Oral Steroids</td>
                        <td align="left" rowspan="1" colspan="1">10 (3) [323]</td>
                        <td align="left" rowspan="1" colspan="1">2 (1) [138]</td>
                        <td align="left" rowspan="1" colspan="1">0 (0) [44]</td>
                        <td align="left" rowspan="1" colspan="1">8 (3) [267]</td>
                        <td align="left" rowspan="1" colspan="1">3 (2) [194]</td>
                        <td align="left" rowspan="1" colspan="1">1 (2) [44]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">NSAIDs</td>
                        <td align="left" rowspan="1" colspan="1">79 (24) [324]</td>
                        <td align="left" rowspan="1" colspan="1">26 (19) [138]</td>
                        <td align="left" rowspan="1" colspan="1">11 (25) [44]</td>
                        <td align="left" rowspan="1" colspan="1">55 (21) [267]</td>
                        <td align="left" rowspan="1" colspan="1">49 (25) [195]</td>
                        <td align="left" rowspan="1" colspan="1">12 (27) [44]</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">History</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Cardiovascular</td>
                        <td align="left" rowspan="1" colspan="1">154 (47) [325]</td>
                        <td align="left" rowspan="1" colspan="1">50 (36) [138]</td>
                        <td align="left" rowspan="1" colspan="1">19 (43) [44]</td>
                        <td align="left" rowspan="1" colspan="1">119 (44) [268]</td>
                        <td align="left" rowspan="1" colspan="1">83 (43) [195]</td>
                        <td align="left" rowspan="1" colspan="1">21 (48) [44]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Excretory</td>
                        <td align="left" rowspan="1" colspan="1">17 (5) [325]</td>
                        <td align="left" rowspan="1" colspan="1">8 (6) [138]</td>
                        <td align="left" rowspan="1" colspan="1">2 (5) [44]</td>
                        <td align="left" rowspan="1" colspan="1">18 (7) [268]</td>
                        <td align="left" rowspan="1" colspan="1">9 (5) [195]</td>
                        <td align="left" rowspan="1" colspan="1">0 (0) [44]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">GERD</td>
                        <td align="left" rowspan="1" colspan="1">49 (69) [71]</td>
                        <td align="left" rowspan="1" colspan="1">24 (69) [35]</td>
                        <td align="left" rowspan="1" colspan="1">10 (83) [12]</td>
                        <td align="left" rowspan="1" colspan="1">42 (72) [58]</td>
                        <td align="left" rowspan="1" colspan="1">30 (65) [46]</td>
                        <td align="left" rowspan="1" colspan="1">11 (79) [14]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Respiratory</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>29 (9)<sup>a</sup> [324]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">29 (21)<sup>b</sup> [138]</td>
                        <td align="left" rowspan="1" colspan="1">10 (23)<sup>b</sup> [44]</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>29 (11)<sup>a</sup> [268]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">28 (14) [194]</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>11 (25)<sup>b</sup> [44]</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Regional node irradiation</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>39 (14)<sup>a</sup> [271]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">40 (34)<sup>b</sup> [119]</td>
                        <td align="left" rowspan="1" colspan="1">17 (46)<sup>b</sup> [37]</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>34 (15)<sup>a</sup> [231]</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">46 (29)<sup>b</sup> [160]</td>
                        <td align="left" rowspan="1" colspan="1">16 (44)<sup>b</sup> [36]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">If chemo, any Taxane</td>
                        <td align="left" rowspan="1" colspan="1">95 (88) [108]</td>
                        <td align="left" rowspan="1" colspan="1">68 (93) [73]</td>
                        <td align="left" rowspan="1" colspan="1">30 (94) [32]</td>
                        <td align="left" rowspan="1" colspan="1">83 (87) [95]</td>
                        <td align="left" rowspan="1" colspan="1">84 (94) [89]</td>
                        <td align="left" rowspan="1" colspan="1">26 (90) [29]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Axillary Dissection (+/‚àí SLND)</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†312</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†128</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†42</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†258</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†183</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†41</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">ALND Only</td>
                        <td align="left" rowspan="1" colspan="1">11 (4)<sup>a</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>23 (18)<sup>b</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>12 (29)<sup>b</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">14 (5)<sup>a</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">19 (10)<sup>a</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>13 (32)<sup>b</sup></bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SLNB Only</td>
                        <td align="left" rowspan="1" colspan="1">270 (87)<sup>a</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>82 (64)<sup>b</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>25 (60)<sup>b</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>224 (87)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">128 (70)<sup>b</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">25 (61)<sup>b</sup>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">ALND &amp; SLNB</td>
                        <td align="left" rowspan="1" colspan="1">31 (10)</td>
                        <td align="left" rowspan="1" colspan="1">23 (18)</td>
                        <td align="left" rowspan="1" colspan="1">5 (12)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>20 (8)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>36 (20)<sup>b</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">3 (7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">If SLND, number ‚â•6</td>
                        <td align="left" rowspan="1" colspan="1">9 (3) [270]</td>
                        <td align="left" rowspan="1" colspan="1">5 (6) [82]</td>
                        <td align="left" rowspan="1" colspan="1">1 (4) [25]</td>
                        <td align="left" rowspan="1" colspan="1">5 (2) [224]</td>
                        <td align="left" rowspan="1" colspan="1">9 (7) [128]</td>
                        <td align="left" rowspan="1" colspan="1">1 (4) [25]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Conservative mastectomy</td>
                        <td align="left" rowspan="1" colspan="1">264 (81) [326]</td>
                        <td align="left" rowspan="1" colspan="1">102 (74) [138]</td>
                        <td align="left" rowspan="1" colspan="1">35 (80) [44]</td>
                        <td align="left" rowspan="1" colspan="1">224 (83) [269]</td>
                        <td align="left" rowspan="1" colspan="1">146 (75) [195]</td>
                        <td align="left" rowspan="1" colspan="1">31 (71) [44]</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Complete treatment</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†323</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†137</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†43</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†268</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†192</td>
                        <td align="left" rowspan="1" colspan="1">N¬†=¬†43</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery</td>
                        <td align="left" rowspan="1" colspan="1">33 (10)</td>
                        <td align="left" rowspan="1" colspan="1">9 (7)</td>
                        <td align="left" rowspan="1" colspan="1">1 (2)</td>
                        <td align="left" rowspan="1" colspan="1">23 (9)</td>
                        <td align="left" rowspan="1" colspan="1">18 (9)</td>
                        <td align="left" rowspan="1" colspan="1">2 (5)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery¬†+¬†Radiotherapy</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>184 (57)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">57 (42)<sup>b</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">13 (30)<sup>b</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>153 (57)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">88 (46)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>13 (30)<sup>b</sup></bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery¬†+¬†Chemotherapy (Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">19 (6)</td>
                        <td align="left" rowspan="1" colspan="1">11 (8)</td>
                        <td align="left" rowspan="1" colspan="1">4 (9)</td>
                        <td align="left" rowspan="1" colspan="1">13 (5)</td>
                        <td align="left" rowspan="1" colspan="1">17 (9)</td>
                        <td align="left" rowspan="1" colspan="1">4 (9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery¬†+¬†Chemotherapy (Not Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">0 (0)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>0 (0)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>1 (2)<sup>b</sup></bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery¬†+¬†Radiotherapy¬†+¬†Chemotherapy (Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>73 (23)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">56 (41)<sup>b</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">24 (56)<sup>b</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>68 (25)<sup>a</sup></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">64 (33)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>21 (49)<sup>b</sup></bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery¬†+¬†Radiotherapy¬†+¬†Chemotherapy (Not Taxane)</td>
                        <td align="left" rowspan="1" colspan="1">13 (4)</td>
                        <td align="left" rowspan="1" colspan="1">3 (2)</td>
                        <td align="left" rowspan="1" colspan="1">1 (2)</td>
                        <td align="left" rowspan="1" colspan="1">11 (4)</td>
                        <td align="left" rowspan="1" colspan="1">4 (2)</td>
                        <td align="left" rowspan="1" colspan="1">2 (5)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="cam43188-ntgp-0003">
                    <fn id="cam43188-note-0003">
                      <p>Bold indicates cell with statistically significant findings (Bonferroni‚Äêcorrected <italic>P</italic>¬†&lt;¬†.05); Superscripts (<sup>a</sup>, <sup>b</sup>) indicate specifically which trajectory patterns defined the difference.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>Group‚Äêbased trajectory analysis as implemented in SAS PROC TRAJ (version 9.4) was used to detect longitudinal patterns of change in L‚ÄêDex values, change in percent arm volume difference via TM, LSIDS‚ÄêA Soft Tissue scores, and FACT‚ÄêB Arm scores beginning prior to treatment and up to 24 months thereafter.<xref rid="cam43188-bib-0012" ref-type="ref"><sup>12</sup></xref> Both Bayesian information criteria and Akaike information criteria (AIC) were used to determine the best trajectory model fit to the biomarkers and self‚Äêreport scores. Trajectory group membership was saved for subsequent plotting of the trajectory patterns and for assessing associations of hypothesized patient and treatment characteristics with those trajectories using likelihood ratio chi‚Äêsquare and Kruskal‚ÄêWallis tests. To capture natural trajectories for the 24‚Äêmonth period, if a patient triggered the study intervention during the subclinical stage or progressed to treatment status without moving through the subclinical stage, assessments only up to and including the last assessment either triggering the prevention intervention or progressing through that trigger (TM: n¬†=¬†79 of 245, BIS: n¬†=¬†48 of 263), were included in the models. <sc>sas</sc> (9.4), S<sc>tata</sc> (13), and <sc>spss</sc> (22) were used for statistical analyses. A maximum Type I error rate of 0.05 (<italic>P</italic>¬†&lt;¬†.05) was used for determining statistical significance. The data that support the findings will be available at <ext-link ext-link-type="ftp" xlink:href="ftp://ftp.impedimed.com">ftp.impedimed.com</ext-link> following an embargo from the date of publication to allow for commercialization of research findings.<xref rid="cam43188-bib-0018" ref-type="ref"><sup>18</sup></xref>
</p>
              </sec>
            </sec>
            <sec sec-type="results" id="cam43188-sec-0015">
              <label>3</label>
              <title>RESULTS</title>
              <sec id="cam43188-sec-0016">
                <label>3.1</label>
                <title>Sample characteristics</title>
                <p>Detailed patient and treatment characteristics for the 508 patients included in the analyses were previously published.<xref rid="cam43188-bib-0003" ref-type="ref"><sup>3</sup></xref> Most patients were white (77%, n¬†=¬†389). Slightly more than a third had Stage II/III disease (39.0%, n¬†=¬†198). Summaries of the characteristics used in these analyses are shown in Table <xref rid="cam43188-tbl-0001" ref-type="table">1</xref>. No statistically significant differences between the groups were observed. Median age was 59¬†years (interquartile range, IQR¬†=¬†50‚Äê67), approximately 74% (n¬†=¬†373 of 507) were either overweight or obese.</p>
              </sec>
              <sec id="cam43188-sec-0017">
                <label>3.2</label>
                <title>Trajectories</title>
                <p>Three trajectories were observed for each of the four measures: changes in L‚ÄêDex obtained by BIS, percent volume difference change by TM, and symptom scores using LSIDS‚ÄêA and FACT‚ÄêB¬†+¬†4. Each biomarker trajectory was categorized as ‚ÄúDecreasing‚Äù, ‚ÄúStable‚Äù or ‚ÄúIncreasing‚Äù over the 24¬†months. Symptom trajectories were characterized as ‚ÄúStable‚Äù, ‚ÄúSlight Increase/Decrease‚Äù or ‚ÄúIncreasing‚Äù as there was not a definitive decreasing trajectory. The patterns are illustrated in Figures <xref rid="cam43188-fig-0001" ref-type="fig">1</xref>, <xref rid="cam43188-fig-0002" ref-type="fig">2</xref>, <xref rid="cam43188-fig-0003" ref-type="fig">3</xref>, <xref rid="cam43188-fig-0004" ref-type="fig">4</xref> and summarized below.</p>
                <fig fig-type="Figure" xml:lang="en" id="cam43188-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>L‚ÄêDex trajectories</p>
                  </caption>
                  <graphic id="nlm-graphic-3" xlink:href="CAM4-9-5164-g001"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="cam43188-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Volume trajectories</p>
                  </caption>
                  <graphic id="nlm-graphic-5" xlink:href="CAM4-9-5164-g002"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="cam43188-fig-0003" orientation="portrait" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>LSIDS‚Äêa soft tissue symptom trajectories</p>
                  </caption>
                  <graphic id="nlm-graphic-7" xlink:href="CAM4-9-5164-g003"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="cam43188-fig-0004" orientation="portrait" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <p>FACT B +4 arm symptom trajectories</p>
                  </caption>
                  <graphic id="nlm-graphic-9" xlink:href="CAM4-9-5164-g004"/>
                </fig>
                <sec id="cam43188-sec-0018">
                  <label>3.2.1</label>
                  <title>L‚ÄêDex</title>
                  <p>Slightly more than half (56%) demonstrated stable values from baseline through 24 months (Figure <xref rid="cam43188-fig-0001" ref-type="fig">1</xref>). Approximately a third demonstrated decreasing L‚ÄêDex values (values lower than baseline, 35%), while 9% demonstrated patterns consistent with increasing L‚ÄêDex values (n¬†=¬†25 of 263). In the group with increasing L‚ÄêDex values over time, increases were initially noted at approximately 3 months postsurgery, and at 15 months postsurgery, a second increase was noted (see Figure <xref rid="cam43188-fig-0001" ref-type="fig">1</xref>). Those patients in the decreasing L‚ÄêDex values trajectory group had higher baseline L‚ÄêDex values (median¬†=¬†2.4, IQR¬†=¬†‚àí1, 5) than did those in the other trajectory groups (stable: median¬†=¬†‚àí1.1, IQR¬†=¬†‚àí4, 2; increasing: median¬†=¬†‚àí3.5, IQR¬†=¬†‚àí6, 0, <italic>P</italic>¬†&lt;¬†.001).</p>
                </sec>
                <sec id="cam43188-sec-0019">
                  <label>3.2.2</label>
                  <title>Percent arm volume difference</title>
                  <p>Slightly more than half (56%) of the patients demonstrated stable arm volume difference, 27% demonstrated a pattern of decreasing difference between arm volumes, and 17% (n¬†=¬†41 of 245) showed increasing arm volume difference (Figure <xref rid="cam43188-fig-0002" ref-type="fig">2</xref>). Increases were initially noted at approximately 3¬†months postsurgery with a steadily increasing slope over time. The percentage of patients assessed with TM, demonstrating the increasing trajectory pattern (17%), was statistically significantly higher than the percentage of those assessed via BIS with increasing trajectories (9%, <italic>P</italic>¬†=¬†.023). Similar to those patients randomized to the BIS assessments, patients with TM assessments, and in the decreasing percent arm volume difference trajectory, had higher baseline values (median¬†=¬†3.0%, IQR¬†=¬†0, 6) than did those in the other trajectories (stable: median¬†=¬†‚àí0.6%, IQR¬†=¬†‚àí4, 2; increasing: median¬†=¬†‚àí2.1%, IQR¬†=¬†‚àí5, 2, <italic>P</italic>¬†&lt;¬†.001.</p>
                </sec>
                <sec id="cam43188-sec-0020">
                  <label>3.2.3</label>
                  <title>LISDS‚ÄîA soft tissue</title>
                  <p>Almost two‚Äêthirds of the patients (64%) had stable soft tissue symptoms over 24 months (Figure <xref rid="cam43188-fig-0003" ref-type="fig">3</xref>). Another 27% had slightly increased symptom reports during the first 12 months after surgery that decreased to near presurgery level by 24¬†months. The remaining 9% (44 of 508) had an increasing trajectory characterized by steady rise in symptoms from baseline to 6¬†months postsurgery and remained well above baseline through 24 months postsurgery.</p>
                </sec>
                <sec id="cam43188-sec-0021">
                  <label>3.2.4</label>
                  <title>FACTB+4</title>
                  <p>Slightly more than half of the patients (53%) had little to no symptoms throughout; 38% demonstrated a pattern of slightly increased symptoms the first 9‚Äê12¬†months after surgery that stabilized and trended downward toward presurgery levels by 24¬†months (Figure <xref rid="cam43188-fig-0004" ref-type="fig">4</xref>). Finally, 9% (n¬†=¬†44 of 508) demonstrated an increasing trajectory of symptoms from baseline to 12 months postsurgery and remained well above baseline through 24 months. Consistent with the similar patterns and proportions of patients in each pattern for the two self‚Äêreport measures, the contingency coefficient for the association was 0.59 (<italic>P</italic>¬†&lt;¬†.001).</p>
                </sec>
              </sec>
              <sec id="cam43188-sec-0022">
                <label>3.3</label>
                <title>Associations among trajectories</title>
                <p>The symptom trajectory groups were statistically significantly associated with distribution of L‚ÄêDex change trajectories but not with percent difference change in arm volume trajectories. The self‚Äêreport sets demonstrated contingency coefficients of 0.20 (LSIDS‚ÄêA soft tissue, <italic>P</italic>¬†=¬†.031) and 0.19 (FACTB+4, <italic>P</italic>¬†=¬†.044) with the set of L‚ÄêDex unit change trajectories. Of the 25 patients in the increasing L‚ÄêDex change trajectory group, 24% (n¬†=¬†6) were also in the increasing LSIDS‚ÄêA soft tissue trajectory and 16% (n¬†=¬†4) in the increasing FACTB+4 trajectory. To the contrary, of the 41 in the increasing percent difference in arm volume change trajectory group, only 10% (n¬†=¬†4) were also in the increasing LSIDS‚ÄêA soft tissue trajectory and 10% (n¬†=¬†4) in the increasing FACTB+4 trajectory.</p>
              </sec>
              <sec id="cam43188-sec-0023">
                <label>3.4</label>
                <title>Patient and treatment characteristics with trajectories</title>
                <p>Summaries of patient and treatment characteristics hypothesized to be associated with the longitudinal patterns of change in biomarkers and symptoms are shown in Tables <xref rid="cam43188-tbl-0001" ref-type="table">1</xref> and <xref rid="cam43188-tbl-0002" ref-type="table">2</xref>.</p>
                <sec id="cam43188-sec-0024">
                  <label>3.4.1</label>
                  <title>Bioelectric impedance spectroscopy</title>
                  <p>Patients in the increasing L‚ÄêDex unit change pattern were older (median 64¬†years) than those in the stable or decreasing change patterns (median 59 and 58 years, respectively). They also were using nonsteroidal antiinflammatory drugs (NSAIDs) (48%) more than those in the stable trajectory group (20%). Patients in the decreasing L‚ÄêDex trajectory were less likely to have a history of cardiovascular conditions (34%) than those in the stable group (50%) (all Bonferroni‚Äêcorrected, <italic>P</italic>¬†&lt;¬†.05, Table <xref rid="cam43188-tbl-0001" ref-type="table">1</xref>).</p>
                </sec>
                <sec id="cam43188-sec-0025">
                  <label>3.4.2</label>
                  <title>Tape</title>
                  <p>Patients in the increasing percent difference in arm volume trajectory were less likely to have a history of gastroesophageal reflux disease (GERD) (40%) than those in the stable group (84%, post hoc corrected <italic>P</italic>¬†&lt;¬†.05, Table <xref rid="cam43188-tbl-0001" ref-type="table">1</xref>).</p>
                </sec>
                <sec id="cam43188-sec-0026">
                  <label>3.4.3</label>
                  <title>Self‚Äêreported symptoms</title>
                  <p>Patients with an increasing (slight or considerable) reported symptom trajectory were slightly younger than those in the group with very few reported symptoms throughout the observation period. They also were more likely to have had a history of respiratory issues (Table <xref rid="cam43188-tbl-0002" ref-type="table">2</xref>). In terms of treatment, compared to those patients with a null symptom trajectory, those characterized by an slight or increasing symptom trajectory were more likely to have axillary lymph node dissection only, regional node irradiation and a combined surgery/radiation/chemo therapy regimen with taxane and less likely to have had surgery/radiation alone (all post hoc corrected <italic>P</italic>¬†&lt;¬†.05, Table <xref rid="cam43188-tbl-0002" ref-type="table">2</xref>).</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="cam43188-sec-0027">
              <label>4</label>
              <title>DISCUSSION</title>
              <p>This study provides longitudinal data regarding the postsurgical patterns of subclinical BCRL needed to inform prospective surveillance guidelines and clinical practice. One trajectory for each biomarker demonstrated slight decreases from baseline; in a second, there was little to no change from baseline measures. These two trajectories suggest that cancer treatment does not always lead to poorer arm status during the first 24¬†months. Subclinical lymphedema was identified in a third trajectory for both BIS and TM groups that continued to rise beyond 12¬†months after surgery. When looking at the characteristics of patients in the increasing trajectory groups for both BIS and TM, it appears that these cohorts include higher rates of regional nodal irradiation, tri‚Äêmodality therapy with taxanes, mastectomies, and patients with elevated Body mass index (BMI)‚Äôs as compared to decreasing and stable trajectories (Table <xref rid="cam43188-tbl-0001" ref-type="table">1</xref>).</p>
              <p>The increasing trajectories for both biomarkers demonstrate that a subset of patients are at high‚Äêrisk of subclinical lymphedema during the first 24 months after surgery; however, due to censoring of participants when subclinical lymphedema was noted, patterns beyond the date of censoring are unknown for either biomarker. Previous trajectory work covering 12 months post operatively, using BIS ratios, identified three trajectories, all described as being ‚Äúrelatively stable‚Äù over 12 months and suggested BIS ratios 1 month postsurgery might predict lymphedema.<xref rid="cam43188-bib-0013" ref-type="ref"><sup>13</sup></xref> In this study, spanning 24 months post surgery, only one stable trajectory was maintained over time. Of clinical importance is the trajectory increase noted in L‚ÄêDex units at 15 months. Long‚Äêterm prospective surveillance is needed through at least 24 months postsurgery and frequent monitoring of patients every 3 months at least through 15 months postsurgery should be considered. Additionally, patients with characteristics similar to those noted in the third trajectories for both BIS and TM (eg, regional nodal irradiation, tri‚Äêmodality therapy with taxanes, mastectomies, and elevated BMI‚Äôs) should be encouraged to contact their providers between scheduled visits if they become symptomatic (new onset swelling or altered sensations in the arm).</p>
              <p>Some patient/treatment factors were associated with trajectories for biomarkers and symptoms. Age, use of NSAIDS, and a history of prior cardiac conditions were associated with increasing L‚ÄêDex trajectories, consistent with previous research.<xref rid="cam43188-bib-0019" ref-type="ref"><sup>19</sup></xref>, <xref rid="cam43188-bib-0020" ref-type="ref"><sup>20</sup></xref> GERD was associated with percent difference change in arm volume. No known studies support an association between GERD and BCRL. This is likely a spurious finding. Until a well‚Äêtested, predictive model that identifies patients who absolutely fall into an increasing trajectory is proven accurate, prospective surveillance using objective biomarkers for all BCS is indicated.</p>
              <p>Regardless of trajectory group, patients reported few to no baseline symptoms. Both symptom clusters were indicative of ongoing issues for about 10% of participants through 24 months after surgery. Being younger, respiratory health issues, type of complete treatment received, and regional nodal irradiation contributed to symptom severity. Younger BCS report more symptoms than do older survivors, therefore the age related findings are not surprising.<xref rid="cam43188-bib-0021" ref-type="ref"><sup>21</sup></xref> Deep breathing improves lymph flow, thus respiratory conditions that constrain breathing might contribute to lymph stasis.<xref rid="cam43188-bib-0022" ref-type="ref"><sup>22</sup></xref> Axillary lymph node dissection and radiation are known to be related to lymphedema, and additional research regarding the extent of surgery to the axilla +/‚àí the extent of radiation to the regional nodes, L‚ÄêDex increases, and symptoms is in preparation.<xref rid="cam43188-bib-0023" ref-type="ref"><sup>23</sup></xref>
</p>
              <p>This study found a second peak in increasing L‚ÄêDex at 15¬†months. McDuff has previously shown that the hazard rate peak for lymphedema after axillary treatment varies by treatment complexity.<xref rid="cam43188-bib-0010" ref-type="ref"><sup>10</sup></xref> In patients who received an axillary dissection alone, the hazard rate of lymphedema development was greatest in the first 6‚Äê12¬†months. For patients who received axillary dissection with regional node irradiation, the hazard rate peaked between 18 and 24¬†months. Whereas in patients undergoing sentinel node biopsy with regional node irradiation, the hazard rate peaked between 36 and 48 months, presumably due to the slower onset of radiation induced changes such as fibrosis. Therefore, clinicians may wish to advise patients with these characteristics to contact them between visits.</p>
              <p>Self‚Äêreported symptoms were associated with L‚ÄêDex changes, but not percent change in arm volume difference. Symptoms have long been considered warning signs in a subset of patients at risk for BCRL.<xref rid="cam43188-bib-0024" ref-type="ref"><sup>24</sup></xref>, <xref rid="cam43188-bib-0025" ref-type="ref"><sup>25</sup></xref> In 2017, the American Physical Therapists Association (APTA) recommended that: (a) self‚Äêreported numbness, heaviness, etc. in at‚Äêrisk patients be assessed using an objective measure, and (b) BIS be used as a measurement tool for diagnosis of subclinical (stage 0) lymphedema.<xref rid="cam43188-bib-0026" ref-type="ref"><sup>26</sup></xref> Symptom severity, from two symptom tools, was statistically significantly associated with L‚ÄêDex changes indicative of subclinical lymphedema, but not with percent change in arm volume difference. This supports APTA‚Äôs recommendation that BIS be used for early identification of subclinical lymphedema, is consistent with previous research,<xref rid="cam43188-bib-0027" ref-type="ref"><sup>27</sup></xref> and is clinically relevant for two primary reasons: First, the symptoms included in this study offer new information regarding symptoms associated with subclinical lymphedema. Second, BIS measurement captured early subclinical lymphedema when self‚Äêreports of symptoms were present which provides evidence to support that BIS can identify subclinical lymphedema. Therefore, L‚ÄêDex can be considered as a confirmatory biomarker for early identification of subclinical lymphedema, especially in the presence of patient‚Äêreported symptoms.</p>
            </sec>
            <sec sec-type="conclusions" id="cam43188-sec-0028">
              <label>5</label>
              <title>CONCLUSIONS</title>
              <p>New onset subclinical lymphedema was experienced by patients in the increasing trajectory across both biomarkers across 24 months postsurgery. These data support the need for prospective surveillance through at least 24 months postsurgery with 3‚Äêmonth assessments in this population, through at least 15 months postsurgery. Statistically significant convergence of symptom cluster scores with L‚ÄêDex unit change support BIS as beneficial in early identification of subclinical lymphedema.</p>
            </sec>
            <sec id="cam43188-sec-0030">
              <title>AUTHOR CONTRIBUTIONS</title>
              <p>Conceptualization and study design‚ÄîRidner, Dietrich, &amp; Shah. Data collection‚ÄîRidner, Boyages, Koelmeyer, Ajkay, DeSnyder, &amp; McLaughlin. Statistical Analysis‚ÄîDietrich. Manuscript development and review: Ridner, Shah, Boyages, Koelmeyer, Ajkay, DeSnyder, McLaughlin, &amp; Dietrich.</p>
            </sec>
          </body>
          <back>
            <ack id="cam43188-sec-0029">
              <title>ACKNOWLEDGEMENT</title>
              <p>The authors would like to thank Frank Vicini, MD for his support of this research.</p>
            </ack>
            <sec sec-type="data-availability" id="cam43188-sec-0032">
              <title>DATA AVAILABILITY</title>
              <p>The data that support the findings will be available at ftp.impedimed.com following an embargo from the date of publication to allow for commercialization of research findings.</p>
            </sec>
            <ref-list content-type="cited-references" id="cam43188-bibl-0001">
              <title>REFERENCES</title>
              <ref id="cam43188-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0001"><string-name><surname>DiSipio</surname><given-names>T</given-names></string-name>, <string-name><surname>Rye</surname><given-names>S</given-names></string-name>, <string-name><surname>Newman</surname><given-names>B</given-names></string-name>, <string-name><surname>Hayes</surname><given-names>S</given-names></string-name>. <article-title>Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta‚Äêanalysis</article-title>. <source xml:lang="en">Lancet Oncol</source>. <year>2013</year>;<volume>14</volume>(<issue>6</issue>):<fpage>500</fpage>‚Äì<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(13)70076-7</pub-id>
<pub-id pub-id-type="pmid">23540561</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0002"><string-name><surname>Stout Gergich</surname><given-names>NL</given-names></string-name>, <string-name><surname>Pfalzer</surname><given-names>LA</given-names></string-name>, <string-name><surname>McGarvey</surname><given-names>C</given-names></string-name>, <string-name><surname>Springer</surname><given-names>B</given-names></string-name>, <string-name><surname>Gerber</surname><given-names>LH</given-names></string-name>, <string-name><surname>Soballe</surname><given-names>P</given-names></string-name>. <article-title>Preoperative assessment enables the early diagnosis and successful treatment of lymphedema</article-title>. <source xml:lang="en">Cancer</source>. <year>2008</year>;<volume>112</volume>(<issue>12</issue>):<fpage>2809</fpage>‚Äì<lpage>2819</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.23494</pub-id>
<pub-id pub-id-type="pmid">18428212</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0003"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>, <string-name><surname>Cowher</surname><given-names>MS</given-names></string-name>, et al. <article-title>A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis</article-title>. <source xml:lang="en">Ann Surg Oncol</source>. <year>2019</year>;<volume>26</volume>(<issue>10</issue>):<fpage>3250</fpage>‚Äì<lpage>3259</lpage>. <pub-id pub-id-type="doi">10.1245/s10434-019-07344-5</pub-id>
<pub-id pub-id-type="pmid">31054038</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0004"><string-name><surname>Koelmeyer</surname><given-names>LA</given-names></string-name>, <string-name><surname>Borotkanics</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Alcorso</surname><given-names>J</given-names></string-name>, et al. <article-title>Early surveillance is associated with less incidence and severity of breast cancer‚Äìrelated lymphedema compared with a traditional referral model of care</article-title>. <source xml:lang="en">Cancer</source>. <year>2019</year>;<volume>125</volume>(<issue>6</issue>):<fpage>854</fpage>‚Äì<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.31873</pub-id>. <pub-id pub-id-type="pmid">30521080</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0005"><string-name><surname>McLaughlin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Staley</surname><given-names>AC</given-names></string-name>, <string-name><surname>Vicini</surname><given-names>F</given-names></string-name>, et al. <article-title>Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer‚Äêrelated lymphedema: recommendations from a multidisciplinary expert ASBrS panel : Part 1: definitions, assessments, education, and future directions</article-title>. <source xml:lang="en">Ann Surg Oncol</source>. <year>2017</year>;<volume>24</volume>(<issue>10</issue>):<fpage>2818</fpage>‚Äì<lpage>2826</lpage>. <pub-id pub-id-type="doi">10.1245/s10434-017-5982-4</pub-id>
<pub-id pub-id-type="pmid">28766232</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0006"><string-name><surname>Shah</surname><given-names>C</given-names></string-name>. <article-title>Bioimpedance spectroscopy in the detection of breast cancer‚Äêrelated lymphedema: an ounce of prevention</article-title>. <source xml:lang="en">Breast J</source>. <year>2019</year>;<volume>25</volume>(<issue>6</issue>):<fpage>1323</fpage>‚Äì<lpage>1325</lpage>. <pub-id pub-id-type="doi">10.1111/tbj.13618</pub-id>
<pub-id pub-id-type="pmid">31518487</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0007"><string-name><surname>Strimbu</surname><given-names>K</given-names></string-name>, <string-name><surname>Tavel</surname><given-names>JA</given-names></string-name>. <article-title>What are biomarkers?</article-title><source xml:lang="en">Curr Opin HIV AIDS</source>. <year>2010</year>;<volume>5</volume>(<issue>6</issue>):<fpage>463</fpage>‚Äì<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1097/COH.0b013e32833ed177</pub-id>
<pub-id pub-id-type="pmid">20978388</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="miscellaneous" id="cam43188-cit-0008"><collab collab-type="authors">INCHEM</collab>
. <article-title>Biomarkers and risk assessment: concepts and principles</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.inchem.org/documents/ehc/ehc/ehc155.htm#SectionNumber:1.2">www.inchem.org/documents/ehc/ehc/ehc155.htm#SectionNumber:1.2</ext-link>. Published 1993. Accessed November 1, 2019, <year>2019</year>.</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0009"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>, <string-name><surname>Spotanski</surname><given-names>K</given-names></string-name>, et al. <article-title>A prospective study of L‚ÄêDex values in breast cancer patients pretreatment and through 12 months postoperatively</article-title>. <source xml:lang="en">Lymphat Res Biol</source>. <year>2018</year>;<volume>16</volume>(<issue>5</issue>):<fpage>435</fpage>‚Äì<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1089/lrb.2017.0070</pub-id>
<pub-id pub-id-type="pmid">30130147</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0010"><string-name><surname>McDuff</surname><given-names>SGR</given-names></string-name>, <string-name><surname>Mina</surname><given-names>AI</given-names></string-name>, <string-name><surname>Brunelle</surname><given-names>CL</given-names></string-name>, et al. <article-title>Timing of lymphedema after treatment for breast cancer: when are patients most at risk?</article-title><source xml:lang="en">Int J Radiat Oncol Biol Phys</source>. <year>2019</year>;<volume>103</volume>(<issue>1</issue>):<fpage>62</fpage>‚Äì<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijrobp.2018.08.036</pub-id>
<pub-id pub-id-type="pmid">30165125</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="miscellaneous" id="cam43188-cit-0011"><collab collab-type="authors">AHRQ.</collab><article-title>Diagnosis and treatment of secondary lymphedema</article-title>. AHRQ <ext-link ext-link-type="uri" xlink:href="https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id66aTA.pdf">https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id66aTA.pdf</ext-link>. Published 2010. Accessed November 1, 2019.</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0012"><string-name><surname>Nagin</surname><given-names>DS</given-names></string-name>, <string-name><surname>Odgers</surname><given-names>CL</given-names></string-name>. <article-title>Group‚Äêbased trajectory modeling in clinical research</article-title>. <source xml:lang="en">Annu Rev Clin Psychol</source>. <year>2010</year>;<volume>6</volume>:<fpage>109</fpage>‚Äì<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.121208.131413</pub-id>
<pub-id pub-id-type="pmid">20192788</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0013"><string-name><surname>Smoot</surname><given-names>B</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>BA</given-names></string-name>, <string-name><surname>Conley</surname><given-names>Y</given-names></string-name>, et al. <article-title>Differences in limb volume trajectories after breast cancer treatment</article-title>. <source xml:lang="en">J Cancer Surviv</source>. <year>2016</year>;<volume>10</volume>(<issue>4</issue>):<fpage>772</fpage>‚Äì<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1007/s11764-015-0507-2</pub-id>
<pub-id pub-id-type="pmid">26678895</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="miscellaneous" id="cam43188-cit-0014"><collab collab-type="authors">ImpediMed</collab>
. <article-title>L‚ÄêDex U400 Datasheet</article-title>. ImpediMed. <ext-link ext-link-type="uri" xlink:href="http://impedimed.com/wp-content/uploads/2019/06/PM-039_Rev_E_L-Dex_U400_Datasheet.pdf">http://impedimed.com/wp‚Äêcontent/uploads/2019/06/PM‚Äê039_Rev_E_L‚ÄêDex_U400_Datasheet.pdf</ext-link>. Published 2019. Accessed November 1, 2019.</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="miscellaneous" id="cam43188-cit-0015"><collab collab-type="authors">FitnessMart</collab>
. <article-title>Gulick II tape measure</article-title>. Country Technologies Inc. <ext-link ext-link-type="uri" xlink:href="https://www.fitnessmart.com/products/gulick-ii-tape-measure?variant=27555940167">https://www.fitnessmart.com/products/gulick‚Äêii‚Äêtape‚Äêmeasure?variant=27555940167</ext-link>. Published 2019. Accessed November 8, 2019.</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0016"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>. <article-title>Development and validation of the lymphedema symptom and intensity survey‚Äêarm</article-title>. <source xml:lang="en">Support Care Cancer</source>. <year>2015</year>;<volume>23</volume>(<issue>10</issue>):<fpage>3103</fpage>‚Äì<lpage>3112</lpage>. <pub-id pub-id-type="doi">10.1007/s00520-015-2684-y</pub-id>
<pub-id pub-id-type="pmid">25752884</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0017"><string-name><surname>Coster</surname><given-names>S</given-names></string-name>, <string-name><surname>Poole</surname><given-names>K</given-names></string-name>, <string-name><surname>Fallowfield</surname><given-names>LJ</given-names></string-name>. <article-title>The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post‚Äêoperatively</article-title>. <source xml:lang="en">Breast Cancer Res Treat</source>. <year>2001</year>;<volume>68</volume>(<issue>3</issue>):<fpage>273</fpage>‚Äì<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1023/a:1012278023233</pub-id>
<pub-id pub-id-type="pmid">11727963</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="miscellaneous" id="cam43188-cit-0018"><collab collab-type="authors">ImpediMed</collab>
(<year>2020</year>) <article-title>24 month L‚ÄêDex, arm volume, and symptom trajectories data. ImpediMed¬Æ, Qld, Australia</article-title>. <ext-link ext-link-type="uri" xlink:href="http://ftp.impedimed.com">ftp.impedimed.com</ext-link>
</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0019"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>. <article-title>Self‚Äêreported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema</article-title>. <source xml:lang="en">Oncol Nurs Forum</source>. <year>2008</year>;<volume>35</volume>(<issue>1</issue>):<fpage>57</fpage>‚Äì<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1188/08.ONF.57-63</pub-id>
<pub-id pub-id-type="pmid">18192153</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0020"><string-name><surname>Beesley</surname><given-names>VL</given-names></string-name>, <string-name><surname>Rowlands</surname><given-names>IJ</given-names></string-name>, <string-name><surname>Hayes</surname><given-names>SC</given-names></string-name>, et al. <article-title>Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema‚Äêspecific supportive care needs in women treated for endometrial cancer</article-title>. <source xml:lang="en">Gynecol Oncol</source>. <year>2015</year>;<volume>136</volume>(<issue>1</issue>):<fpage>87</fpage>‚Äì<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2014.11.006</pub-id>
<pub-id pub-id-type="pmid">25448454</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0021"><string-name><surname>Yfantis</surname><given-names>A</given-names></string-name>, <string-name><surname>Intas</surname><given-names>G</given-names></string-name>, <string-name><surname>Tolia</surname><given-names>M</given-names></string-name>, et al. <article-title>Health‚Äêrelated quality of life of young women with breast cancer. Review of the literature</article-title>. <source xml:lang="en">J Buon</source>. <year>2018</year>;<volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>‚Äì<lpage>6</lpage>. Published 2018/03/20.</mixed-citation>
              </ref>
              <ref id="cam43188-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0022"><string-name><surname>Moseley</surname><given-names>AL</given-names></string-name>, <string-name><surname>Piller</surname><given-names>NB</given-names></string-name>, <string-name><surname>Carati</surname><given-names>CJ</given-names></string-name>. <article-title>The effect of gentle arm exercise and deep breathing on secondary arm lymphedema</article-title>. <source xml:lang="en">Lymphology</source>. <year>2005</year>;<volume>38</volume>(<issue>3</issue>):<fpage>136</fpage>‚Äì<lpage>145</lpage>. Published 2005/12/16.<pub-id pub-id-type="pmid">16353491</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0023"><string-name><surname>Donker</surname><given-names>M</given-names></string-name>, <string-name><surname>van Tienhoven</surname><given-names>G</given-names></string-name>, <string-name><surname>Straver</surname><given-names>ME</given-names></string-name>, et al. <article-title>Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981‚Äì22023 AMAROS): a randomised, multicentre, open‚Äêlabel, phase 3 non‚Äêinferiority trial</article-title>. <source xml:lang="en">Lancet Oncol</source>. <year>2014</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1303</fpage>‚Äì<lpage>1310</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(14)70460-7</pub-id>
<pub-id pub-id-type="pmid">25439688</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0024"><string-name><surname>Kosir</surname><given-names>MA</given-names></string-name>, <string-name><surname>Rymal</surname><given-names>C</given-names></string-name>, <string-name><surname>Koppolu</surname><given-names>P</given-names></string-name>, et al. <article-title>Surgical outcomes after breast cancer surgery: measuring acute lymphedema</article-title>. <source xml:lang="en">J Surg Res</source>. <year>2001</year>;<volume>95</volume>(<issue>2</issue>):<fpage>147</fpage>‚Äì<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1006/jsre.2000.6021</pub-id>
<pub-id pub-id-type="pmid">11162038</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0025"><string-name><surname>Armer</surname><given-names>JM</given-names></string-name>, <string-name><surname>Radina</surname><given-names>ME</given-names></string-name>, <string-name><surname>Porock</surname><given-names>D</given-names></string-name>, <string-name><surname>Culbertson</surname><given-names>SD</given-names></string-name>. <article-title>Predicting breast cancer‚Äêrelated lymphedema using self‚Äêreported symptoms</article-title>. <source xml:lang="en">Nurs Res</source>. <year>2003</year>;<volume>52</volume>(<issue>6</issue>):<fpage>370</fpage>‚Äì<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1097/00006199-200311000-00004</pub-id>
<pub-id pub-id-type="pmid">14639083</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0026"><string-name><surname>Levenhagen</surname><given-names>K</given-names></string-name>, <string-name><surname>Davies</surname><given-names>C</given-names></string-name>, <string-name><surname>Perdomo</surname><given-names>M</given-names></string-name>, <string-name><surname>Ryans</surname><given-names>K</given-names></string-name>, <string-name><surname>Gilchrist</surname><given-names>L</given-names></string-name>. <article-title>Diagnosis of upper‚Äêquadrant lymphedema secondary to cancer: clinical practice guideline from the oncology section of APTA</article-title>. <source xml:lang="en">Rehabil Oncol</source>. <year>2017</year>;<volume>35</volume>(<issue>3</issue>):<fpage>E1</fpage>‚Äì<lpage>E18</lpage>. <pub-id pub-id-type="doi">10.1097/01.REO.0000000000000073</pub-id>
<pub-id pub-id-type="pmid">28748128</pub-id></mixed-citation>
              </ref>
              <ref id="cam43188-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="cam43188-cit-0027"><string-name><surname>Czerniec</surname><given-names>SA</given-names></string-name>, <string-name><surname>Ward</surname><given-names>LC</given-names></string-name>, <string-name><surname>Refshauge</surname><given-names>KM</given-names></string-name>, et al. <article-title>Assessment of breast cancer‚Äêrelated arm lymphedema‚Äìcomparison of physical measurement methods and self‚Äêreport</article-title>. <source xml:lang="en">Cancer Invest</source>. <year>2010</year>;<volume>28</volume>(<issue>1</issue>):<fpage>54</fpage>‚Äì<lpage>62</lpage>. <pub-id pub-id-type="doi">10.3109/07357900902918494</pub-id>
<pub-id pub-id-type="pmid">19916749</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
